Author:
Olde Hartman T. C.,Tak L. M.
Reference17 articles.
1. Agger, J. L., Schroder, A., Gormsen, L. K., Jensen, J. S., Jensen, T. S., & Fink, P. K. (2017). Imipramine versus placebo for multiple functional somatic syndromes (STreSS-3): A double-blind, randomised study. Lancet Psychiatry, 4(5), 378–388.
2. American Psychiatric Association (2014). Handboek voor de classificatie van psychische stoornissen DSM 5. Amsterdam: Uitgeverij Boom.
3. Boom, K. J. van der, & Houtveen, J. H. (2014). Psychiatric comorbidity in patients in tertiary care suffering from severe somatoform disorders. Tijdschrift voor Psychiatrie, 56(11), 743–747.
4. Dessel, N. van, Boeft, M. den, Wouden, J. C. van der, Kleinstauber, M., Leone, S. S., Terluin, B., et al. (2014). Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults. Cochrane Database Systematic Review, 11, CD011142.
5. Koelen, J. A., Houtveen, J. H., Abbass, A., Luyten, P., Eurelings-Bontekoe, E. H., Broeckhuysen-Kloth, S. A. van, et al. (2014). Effectiveness of psychotherapy for severe somatoform disorder: Meta-analysis. The British Journal of Psychiatry, 204(1), 12–19.